Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Sep 6;379(10):975-977.
doi: 10.1056/NEJMe1810815.

A Step Forward in the Treatment of Influenza

Timothy M Uyeki  1
Affiliations
Editorial

A Step Forward in the Treatment of Influenza

Timothy M Uyeki. N Engl J Med. .
No abstract available

PubMed Disclaimer

Comment on

  • Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.
    Hayden FG, Sugaya N, Hirotsu N, Lee N, de Jong MD, Hurt AC, Ishida T, Sekino H, Yamada K, Portsmouth S, Kawaguchi K, Shishido T, Arai M, Tsuchiya K, Uehara T, Watanabe A; Baloxavir Marboxil Investigators Group. Hayden FG, et al. N Engl J Med. 2018 Sep 6;379(10):913-923. doi: 10.1056/NEJMoa1716197. N Engl J Med. 2018. PMID: 30184455 Clinical Trial.

References

    1. Influenza antiviral medications: summary for clinicians Atlanta: Centers for Disease Control and Prevention; (https://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm).
    1. WHO guidelines for pharmacological management of pandemic influenza A(H1N1) 2009 and other influenza viruses: revised February 2010 Geneva: World Health Organization; (http://www.who.int/csr/resources/publications/swineflu/h1n1_guidelines_p...). - PubMed
    1. Hurt AC, Chotpitayasunondh T, Cox NJ, et al. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect Dis 2012;12:240–8. - PubMed
    1. Hayden FG, Sugaya N, Hirotsu N, et al. Baloxavir marboxil for uncomplicated influenza in adults and adolescents. N Engl J Med 2018;379:913–23. - PubMed
    1. Omoto S, Speranzini V, Hashimoto T, et al. Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil. Sci Rep 2018;8:9633. - PMC - PubMed